Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy

Increasing evidences show that unmodified extracellular vesicles (EVs) derived from various cells can effectively inhibit the malignant progression of different types of tumors by delivering the bioactive molecules. Therefore, EVs are expected to be developed as emerging anticancer drugs. Meanwhile,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Manling, Wang, Min, Jia, Haoyuan, Wu, Peipei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347476/
https://www.ncbi.nlm.nih.gov/pubmed/35915054
http://dx.doi.org/10.1080/10717544.2022.2104404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347476/
https://www.ncbi.nlm.nih.gov/pubmed/35915054
http://dx.doi.org/10.1080/10717544.2022.2104404

Ejemplares similares